Literature DB >> 24937823

Abscess resulting from Mycobacterium kansasii in the left thigh of AIDS patient.

Catarina Tenório de Lima1, Vera Magalhães1.   

Abstract

A case of abscess resulting from Mycobacterium kansasii, in the left thigh of a 53-year-old woman infected with the Human Immunodeficiency virus, is reported. Curiously, there was no pulmonary or systemic involvement as is usual with these Mycobacterium infections. The patient had CD4 T lymphocyte count of 257 cells/µL and a viral load of 60,154 copies. Despite presenting a relatively preserved immunity, the patient also presented Criptococcic meningoencephalitis and Esophageal candidiasis. The patient responded satisfactorily to treatment for infections and after 51 days was discharged.

Entities:  

Mesh:

Year:  2014        PMID: 24937823      PMCID: PMC4056707          DOI: 10.1590/abd1806-4841.20142741

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  8 in total

Review 1.  Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.

Authors:  Sang Hoon Han; Kyoung Min Kim; Bum Sik Chin; Suk Hoon Choi; Han Sung Lee; Myung Soo Kim; Su Jin Jeong; Hee Kyoung Choi; Chang Oh Kim; Jun Yong Choi; Young Goo Song; June Myung Kim
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

2.  Septic subacromial bursitis caused by Mycobacterium kansasii in an immunocompromised host.

Authors:  Stephanie D Mathew; Charla C Tully; Himabindu Borra; Michael D Berven; Ramon Arroyo
Journal:  Mil Med       Date:  2012-05       Impact factor: 1.437

3.  Mycobacterium kansasii cutaneous abscesses occurring as immune reconstitution inflammatory syndrome.

Authors:  Elizabeth Connick; Marilyn E Levi
Journal:  Int J Tuberc Lung Dis       Date:  2011-07       Impact factor: 2.373

Review 4.  Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin.

Authors:  T Tartaglione
Journal:  Clin Ther       Date:  1997 Jul-Aug       Impact factor: 3.393

5.  Cutaneous Mycobacterium kansasii infection in a patient with AIDS post initiation of antiretroviral therapy.

Authors:  Mohammed Mitha; Preneshni Naicker; Jantjie Taljaard
Journal:  J Infect Dev Ctries       Date:  2011-07-27       Impact factor: 0.968

6.  Mycobacterium kansasii osteomyelitis in a patient with AIDS on highly active antiretroviral therapy.

Authors:  Tomofumi Yano; Sachiko Okuda; Ken-Ichi Kato; Katsuya Kato; Takumi Kishimoto
Journal:  Intern Med       Date:  2004-11       Impact factor: 1.271

7.  Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.

Authors:  J C Tompkins; R S Witzig
Journal:  Int J Tuberc Lung Dis       Date:  2007-03       Impact factor: 2.373

8.  Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study.

Authors:  R Manfredi; A Nanetti; R Valentini; M Ferri; S Morelli; L Calza
Journal:  HIV Med       Date:  2004-11       Impact factor: 3.180

  8 in total
  1 in total

1.  Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.

Authors:  Xiaolong Tang; He Zhu; Ledong Sun; Wei Hou; Shuyu Cai; Rongbo Zhang; Feng Liu
Journal:  Int J Nanomedicine       Date:  2014-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.